Skip to main content
. 2020 May 5;26(4):2225–2235. doi: 10.1007/s12253-020-00814-2

Fig. 1.

Fig. 1

PD-L1 expression levels using different assessments n, number; HER2, human epidermal growth factor receptor 2; TPS, tumor proportion score; TAI, tumor associated immune cells; CPS, combined positive score. Positivity of each assessment (except interface pattern) are demonstrated in continuous variables within X-axis